Search

Your search keyword '"Shafi, Saba"' showing total 278 results
Start Over Author "Shafi, Saba"
278 results on '"Shafi, Saba"'

2. List of contributors

Author

Ahn, Joseph C., primary, Anand, Shankara, additional, Arnaout, O., additional, Bandyopadhyay, Anuja, additional, Bartholomew, Erin, additional, Bates, David W., additional, Bender, Sarah M.L., additional, Bhullar, Puneet K., additional, Bhutani, Tina, additional, Boaro, A., additional, Boyer, Edward W., additional, Brown, Ethan D.L., additional, Carreiro, Stephanie, additional, Chahla, Jorge, additional, Chandran, Viji Pulikkel, additional, Cheng, Ching-Yu, additional, Cheung, Carol Y., additional, Choudhary, Anirudh, additional, Choudhury, Avishek, additional, Chung, Mimi, additional, Ciurtin, Coziana, additional, Comfere, Nneka I., additional, Corriveau-Lecavalier, Nick, additional, Côté, Mélina, additional, del Alamo, Diego, additional, Dias, Roger D., additional, Dönnes, Pierre, additional, Duong, Dat, additional, Ebnali, Mahdi, additional, El Sherbini, Adham, additional, ElZarrad, M. Khair, additional, Fakhouri, Tala H., additional, Fakhoury, Marc, additional, Fein, Joshua A., additional, Fischer, Uwe M., additional, Glicksberg, Benjamin S., additional, Goldstein, Cathy, additional, Gonem, Sherif, additional, Green, Darren V.S., additional, Gupta, Raghav, additional, Hakimi, Marwa, additional, Halamka, John D., additional, Han, Christina S., additional, Hannah-Shmouni, Fady, additional, Harrer, Stefan, additional, Hazime, Ali Amer, additional, Howard, Michael A., additional, Hui, Herbert Y.H., additional, Ildardashty, Alexander, additional, J.F. Shaikh, Hashim, additional, Jeliazkov, Jeliazko R., additional, Jones, David T., additional, Juhn, Young J., additional, Jury, Elizabeth C., additional, Kandaswamy, Swaminathan, additional, Kang, Yanna, additional, Kann, Benjamin H., additional, Kaplin, Scott, additional, Karpiak, Joel, additional, Kassir, Elias, additional, Kaur, Harsimran, additional, Khan, Sohil, additional, Khatib, Reem, additional, Kherabi, Yousra, additional, Knake, Lindsey A., additional, Krittanawong, Chayakrit, additional, Kuhn, Veronica C., additional, Kunze, Kyle, additional, Lamarche, Benoît, additional, Laplante, Simon, additional, Lehmann, Lisa Soleymani, additional, Li, Dawei, additional, Liao, Wilson, additional, Likitlersuang, Jirapat, additional, Liu, Qi, additional, Madani, Amin, additional, Malik, Momin M., additional, Mann, Matthias, additional, Masood, Sameer, additional, Mathur, Piyush, additional, McManus, Sean, additional, Menard, Jeffrey, additional, Mivalt, Filip, additional, Murphree, Dennis, additional, Myers, Thomas G., additional, Narayan, Sanjiv M., additional, Natarajan, Vivek, additional, Pandav, Krunal, additional, Parwani, Anil V., additional, Pedraza Bermeo, Adriana Marcela, additional, Peiffer-Smadja, Nathan, additional, Peng, Junjie, additional, Peng, Lily, additional, Peters, Margot S., additional, Petrick, Nicholas, additional, Polce, Evan, additional, Poojari, Pooja Gopal, additional, Price, W. Nicholson, additional, Raghavan, Lavanya, additional, Rajan, Asha K., additional, Ran, An Ran, additional, Rangu, Sowmith, additional, Rashid, Muhammed, additional, Reddy, Charitha D., additional, Rider, Nicholas L., additional, Rigatti, Marc, additional, Rivers, Michael, additional, Robinson, George, additional, Rogers, Albert J., additional, Rogerson, Colin M., additional, Ryu, Euijung, additional, Sahiner, Berkman, additional, Sarnaik, Kunaal, additional, Shafi, Saba, additional, Shah, Vijay H., additional, Shapovalov, Maxim V., additional, Sharma, Samin K, additional, Shekhar, Skand, additional, Shin, Harold, additional, Shouval, Roni, additional, Smith, Kenneth, additional, Sokumbi, Olayemi, additional, Solomon, Benjamin D., additional, Somani, Sulaiman S., additional, Sternke, Matt C., additional, Strauss, Maximillian T., additional, Syrowatka, Ania, additional, Tang, W. H. Wilson, additional, Teven, Chad M., additional, Tewari, Ashutosh Kumar, additional, Thunga, Girish, additional, Urena, Estefania, additional, Verma, Ashish, additional, Vietas, Jay, additional, Waikel, Rebekah L., additional, Wi, Chung-Il, additional, Winter, Meredith C., additional, Wong, Melissa S., additional, Wong, Tien Yin, additional, Wu, Chao-Ping, additional, Yeroushalmi, Samuel, additional, Zenati, Marco A., additional, Zeng, Wen-Feng, additional, and Zheng, Yingfeng, additional

Published
2024
Full Text
View/download PDF

5. Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

Author

Fanucci, Kristina A., Bai, Yalai, Pelekanou, Vasiliki, Nahleh, Zeina A., Shafi, Saba, Burela, Sneha, Barlow, William E., Sharma, Priyanka, Thompson, Alastair M., Godwin, Andrew K., Rimm, David L., Hortobagyi, Gabriel N., Liu, Yihan, Wang, Leona, Wei, Wei, Pusztai, Lajos, and Blenman, Kim R. M.

Published
2023
Full Text
View/download PDF

11. Development of an immunohistochemical assay for Siglec-15

Author

Shafi, Saba, Aung, Thazin Nwe, Robbins, Charles, Zugazagoitia, Jon, Vathiotis, Ioannis, Gavrielatou, Niki, Yaghoobi, Vesal, Fernandez, Aileen, Niu, Shuqiong, Liu, Linda N., Cusumano, Zachary T., Leelatian, Nalin, Cole, Kimberley, Wang, He, Homer, Robert, Herbst, Roy S., Langermann, Sol, and Rimm, David L.

Published
2022
Full Text
View/download PDF

18. Whole Slide Imaging Technology and Its Applications: Current and Emerging Perspectives.

Author

Jain, Ekta, Patel, Ankush, Parwani, Anil V., Shafi, Saba, Brar, Zoya, Sharma, Shivani, and Mohanty, Sambit K.

Subjects
TECHNOLOGICAL innovations, INTERNET access, SURGICAL pathology, DRUG approval, IMAGE analysis, FORENSIC pathology
Abstract

Background. Whole slide imaging (WSI) represents a paradigm shift in pathology, serving as a necessary first step for a wide array of digital tools to enter the field. It utilizes virtual microscopy wherein glass slides are converted into digital slides and are viewed by pathologists by automated image analysis. Its impact on pathology workflow, reproducibility, dissemination of educational material, expansion of service to underprivileged areas, and institutional collaboration exemplifies a significant innovative movement. The recent US Food and Drug Administration approval to WSI for its use in primary surgical pathology diagnosis has opened opportunities for wider application of this technology in routine practice. Main Text. The ongoing technological advances in digital scanners, image visualization methods, and the integration of artificial intelligence-derived algorithms with these systems provide avenues to exploit its applications. Its benefits are innumerable such as ease of access through the internet, avoidance of physical storage space, and no risk of deterioration of staining quality or breakage of slides to name a few. Although the benefits of WSI to pathology practices are many, the complexities of implementation remain an obstacle to widespread adoption. Some barriers including the high cost, technical glitches, and most importantly professional hesitation to adopt a new technology have hindered its use in routine pathology. Conclusions. In this review, we summarize the technical aspects of WSI, its applications in diagnostic pathology, training, and research along with future perspectives. It also highlights improved understanding of the current challenges to implementation, as well as the benefits and successes of the technology. WSI provides a golden opportunity for pathologists to guide its evolution, standardization, and implementation to better acquaint them with the key aspects of this technology and its judicial use. Also, implementation of routine digital pathology is an extra step requiring resources which (currently) does not usually result increased efficiency or payment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. FIGURE 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

25. FIGURE 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Table 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Materials and Methods from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Table 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 6 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

37. Data from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

38. FIGURE 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

40. TABLE 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

41. Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, additional, Papaxoinis, George, additional, Economopoulou, Panagiota, additional, Kotsantis, Ioannis, additional, Gkotzamanidou, Maria, additional, Anastasiou, Maria, additional, Pectasides, Dimitrios, additional, Kyrodimos, Efthymios, additional, Delides, Alexander, additional, Giotakis, Evangelos, additional, Papadimitriou, Nikolaos G., additional, Panayiotides, Ioannis G., additional, Perisanidis, Christos, additional, Fernandez, Aileen I., additional, Xirou, Vasiliki, additional, Poulios, Christos, additional, Gagari, Eleni, additional, Yaghoobi, Vesal, additional, Gavrielatou, Niki, additional, Shafi, Saba, additional, Aung, Thazin Nwe, additional, Kougioumtzopoulou, Andromachi, additional, Kouloulias, Vassilis, additional, Palialexis, Konstantinos, additional, Gkolfinopoulos, Stavros, additional, Strati, Areti, additional, Lianidou, Evi, additional, Fountzilas, George, additional, Rimm, David L., additional, Foukas, Periklis G., additional, and Psyrri, Amanda, additional

Published
2023
Full Text
View/download PDF

43. Supplemental Figure 1 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

44. Supplemental Table 1 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

45. Supplemental Figure 4 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

46. Supplemental Figure 2 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

47. Supplemental Figure 6 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

48. Supplemental Figure 5 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

49. Data from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

50. Supplemental Figure 3 from Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma

Author

Gavrielatou, Niki, primary, Vathiotis, Ioannis, primary, Aung, Thazin Nwe, primary, Shafi, Saba, primary, Burela, Sneha, primary, Fernandez, Aileen I., primary, Moutafi, Myrto, primary, Burtness, Barbara, primary, Economopoulou, Panagiota, primary, Anastasiou, Maria, primary, Foukas, Periklis, primary, Psyrri, Amanda, primary, and Rimm, David L., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results